Trial Profile
(Study: Vertex IIS) A Study To Access the Effects of Ivacaftor on Wild Type CFTR-Open Probability (PO) In The Sweat Gland Secretory Coil
Status:
Completed
Phase of Trial:
Phase 0
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Ivacaftor (Primary)
- Indications Cystic fibrosis
- Focus Pharmacodynamics
- Acronyms Vertex IIS
- 19 Mar 2018 Status changed from active, no longer recruiting to completed.
- 23 Apr 2016 Status changed from recruiting to active, no longer recruiting.
- 05 Aug 2015 Planned End Date changed from 1 Dec 2015 to 1 Dec 2016 as per ClinicalTrials.gov record.